Filing Details
- Accession Number:
- 0001225208-11-025274
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-11-22 17:07:33
- Reporting Period:
- 2011-11-17
- Filing Date:
- 2011-11-22
- Accepted Time:
- 2011-11-22 17:07:33
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
810509 | Neoprobe Corp | NEOP | Surgical & Medical Instruments & Apparatus (3841) | 311080091 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1195757 | C David Bupp | 425 Metro Place North Suite 300 Dublin OH 43017 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2011-11-17 | 10,000 | $2.27 | 2,516,428 | No | 4 | S | Direct | |
Common Stock | Disposition | 2011-11-18 | 6,100 | $2.25 | 2,510,328 | No | 4 | S | Direct | |
Common Stock | Disposition | 2011-11-21 | 10,000 | $2.19 | 2,500,328 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 129,056 | Indirect | By 401(k) |
Common Stock | 213,746 | Indirect | By Spouse |
Footnotes
- The sales in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Bupp on September 13, 2011.
- Price represents a weighted average of the sale price. Shares were sold at prices ranging from $2.26 to $2.30. Upon the request by the SEC staff, the Issuer, or a security holder of the Issuer, the reporting person will provide the full information about the number of shares sold at each separate price.
- Price represents a weighted average of the sale price. Shares were sold at prices ranging from $2.25 to $2.26. Upon the request by the SEC staff, the Issuer, or a security holder of the Issuer, the reporting person will provide the full information about the number of shares sold at each separate price.
- Price represents a weighted average of the sale price. Shares were sold at prices ranging from $2.15 to $2.22. Upon the request by the SEC staff, the Issuer, or a security holder of the Issuer, the reporting person will provide the full information about the number of shares sold at each separate price.